Related Experiment Video
Updated: Jul 7, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Inpatient Outcomes for Myocarditis-Related Heart Failure
Mohammad Alabbas1, Cheryl Gibson2, Abdulrahman Morad3
1Internal Medicine, University of Debrecen, Debrecen, Hungary.
Insights
Myocarditis-associated heart failure (HF) leads to worse outcomes, including higher inpatient mortality and longer hospital stays compared to HF without myocarditis. This highlights the critical impact of myocarditis on HF patient prognosis.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Heart failure (HF) is a major cause of hospitalization and mortality in the US.
- Myocarditis is an understudied cause of HF with significant implications.
Purpose of the Study:
- To compare inpatient outcomes between HF patients with and without myocarditis.
- To understand the specific impact of myocarditis on HF patient prognosis and resource utilization.
Main Methods:
- Utilized the Nationwide Readmissions Database (2016-2019) for adult HF admissions.
- Compared outcomes between HF without myocarditis and myocarditis-associated HF (MAHF) using propensity score-weighted models.
- Applied survey procedures and SAS 9.4 for statistical analysis.
Main Results:
- MAHF patients were younger (53 vs. 72 years) and had fewer women (45% vs. 48%).
- MAHF cases experienced more inpatient complications (cardiac arrest, cardiogenic shock, mechanical support) despite fewer comorbidities.
- MAHF was associated with longer hospital stays (9.2 vs. 5.5 days) and significantly higher in-hospital mortality (3.9% vs. 2.8%).
Conclusions:
- Myocarditis-associated HF significantly increases inpatient mortality.
- MAHF leads to greater resource utilization and prolonged hospitalizations.
- Myocarditis is a critical predictor of inpatient mortality in heart failure patients.
Abstract:
Background Heart failure (HF) is one of the leading causes of hospitalizations among adults, accounting for high rates of morbidity and mortality in the United States. Myocarditis is a less common etiology of HF, and its outcomes are less well understood. Methods We used the Nationwide Readmissions Database from 2016 to 2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year studied. We excluded patients with missing data on event time or length of stay. Inpatient outcomes were compared between cases of HF without myocarditis and myocarditis-associated HF (MAHF). Survey procedures were applied. Propensity scores as covariates were used in survey-weighted models to estimate the population average treatment effect on the treated using SAS 9.4. Results We included 4,454,272 HF-related weighted admissions for which 4,605 patients (0.1%) had a concurrent diagnosis of myocarditis. Overall, patients with MAHF, compared with HF without myocarditis, were younger (mean age: 53 years vs. 72 years, p < 0.001) with fewer women (45 vs. 48%), respectively. Patients with MAHF had more inpatient complications including cardiac arrest, cardiogenic shock, and use of mechanical circulatory support ( p < 0.001) despite having fewer comorbidities such as diabetes, hypertension, and renal disease. Patients with MAHF had longer mean lengths of stay (9.2 vs. 5.5 days, p < 0.001). In-hospital mortality during index admission was significantly higher in MAHF at 3.9% compared with 2.8% for HF without myocarditis ( p < 0.001). Myocarditis was a key predictor of inpatient mortality adjusting for risk factors. Conclusion Myocarditis-related HF is associated with increased inpatient mortality, resource utilization, and prolonged hospitalization.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

